|
|
|
Volumn 9, Issue 4, 1999, Pages 254-269
|
|
Metabolic effects of protease inhibitor therapy
|
|
Author keywords
Antiretroviral therapy; Complications, drug related; Complications, endocrine; Human immunodeficiency virus (HIV); Lipodystrophy
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
PROTEINASE INHIBITOR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ENDOCRINE SYSTEM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
INSULIN RESISTANCE;
LIPODYSTROPHY;
METABOLIC DISORDER;
OBESITY;
PROTEINASE INHIBITION;
REVIEW;
BODY COMPOSITION;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HIV ASSOCIATED LIPODYSTROPHY;
RISK FACTOR;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
BODY COMPOSITION;
HIV SEROPOSITIVITY;
HIV-ASSOCIATED LIPODYSTROPHY SYNDROME;
HUMANS;
HYPERLIPIDEMIAS;
INSULIN RESISTANCE;
PROTEASE INHIBITORS;
RISK FACTORS;
|
|
EID: 0032807851
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (20)
|
|
References (46)
|
